New tool could support “faster diagnosis” of Parkinson’s disease psychosis

News

Author: Saskia MairPublished: 24 September 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Shot of a doctor showing a patient some information on a digital tablet

A new screening tool has been developed to support the early diagnosis of Parkinson’s disease psychosis – a symptom of the condition that is often misdiagnosed.

Created by Canadian senior care software company, PointClickCare and membership organisation, the American Society of Consultant Pharmacists (ASCP), the platform asks questions on topics like hallucinations and delusions. Healthcare workers can then review the responses and decide to collect more information and create a care plan. Data collected through the tool will also be used to help scientific research in healthcare organisations.

Bill Stuart, clinical product strategist at PointClickCare said: “Not only will the screener tool better enable faster diagnosis, it will provide the senior care industry with a consistent way of approaching Parkinson’s psychosis.”

Chad Worz, chief executive of ASCP, added: “We are excited to have another tool for care teams to facilitate a more standardised care process for Parkinson’s disease and we are excited for the role that pharmacists play in this process.”


Read more:

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

Go Back

Share this story

Comments


Related articles


A woman sits with her knees up on the edge of her bed.

Special reports

Ask the expert: How does Parkinson’s disease impact dreams?

Dr Daniele Urso shares insights and advice on sleep disturbance

READ MORE
Tonya Walker behind the scenes lead

Perspectives

Tonya’s trends: timing is everything when managing Parkinson’s symptoms

How I juggle medication schedules with my busy lifestyle

READ MORE
Parkinson's Choir

Health & Fitness

Parkinson’s Choir: Singing away symptoms

Singing group is improving symptoms in patients

READ MORE